Timothy Colin Hardman

10PUBLICATIONS
53CO-AUTHORS
Pacific Peoples biomedical and clinical scienceEpidemiological modellingSoftware testing, verification and validationInnate immunityGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 08, 2026
Why do healthy volunteers participate in clinical trials?

Thijs van Iersel, Jelle Klein, Timothy C Hardman

|Aug 28, 2025
Urinary thromboxane and isoprostane levels are elevated in symptom-high T2-biomarker-low severe asthma.

Matthew Chad Eastwood, John Busby, Johan Kolmert

|Jun 14, 2023
The future of clinical trials and drug development: 2050.

Timothy C Hardman, Rob Aitchison, Richard Scaife

|Nov 17, 2022
Analysis of the safety and immunogenicity profile of an azoximer bromide polymer-adjuvanted subunit influenza vaccine.

Ronald Kompier, Pieter Neels, Walter Beyer

|May 13, 2022
Exacerbation Profile and Risk Factors in a Type-2-Low Enriched Severe Asthma Cohort: A Clinical Trial to Assess Asthma Exacerbation Phenotypes.

P Jane McDowell, John Busby, Catherine E Hanratty

|Mar 21, 2022
Open-label use of an aliphatic polyamine immunomodulator in patients hospitalized with COVID-19.

Sergey V Efimov, Natallia V Matsiyeuskaya, Olga V Boytsova

Pageof 2

Frequent Collaborators

3 joint publications

Adel Mansur

2 joint publications

Sergey V Efimov

2 joint publications

Natallia V Matsiyeuskaya

2 joint publications

Olga V Boytsova